Indegene, a digital-first, life sciences commercialization company, announced the acquisition of Trilogy Writing & Consulting GmbH (Trilogy), a global provider of specialty medical writing capabilities across clinical, regulatory, safety and medical content to life sciences companies. The acquisition by Indegene Ireland, a subsidiary of Indegene Limited, augments Indegene’s depth of clinical and regulatory writing expertise for market authorization applications globally. Trilogy Writing & Consulting is a Germany, UK, and US-based, medical writing consultancy with know-how in the development and delivery of clinical, regulatory, safety, and medical content. It applies its expertise and unique approaches to deliver quality medical writing output.
Read the full article: Indegene Acquires Trilogy Writing & Consulting GmbH, a Medical Writing Consultancy //
Source: https://www.globenewswire.com/news-release/2024/03/28/2853704/0/en/Indegene-acquires-Trilogy-Writing-Consulting-GmbH-a-medical-writing-consultancy.html